Form 4: GoodRx Holdings Executive Romin Nabiey Reports Stock Transactions

Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units on October 15, 2024.

Summary

• On October 15, 2024, Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, Inc., engaged in transactions involving Class A Common Stock and Restricted Stock Units.
• Nabiey acquired 2,606 shares of Class A Common Stock through the vesting of Restricted Stock Units.
• Simultaneously, 930 shares were disposed of to cover tax obligations at a price of $6.91 per share.
• Following these transactions, Nabiey directly owns 74,305 shares of Class A Common Stock and 2,606 Restricted Stock Units.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing primarily reports routine stock transactions related to executive compensation and tax obligations.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be an indicator of management's perspective on the company's valuation and future prospects.

Comparison to Industry Standards

• Monitoring insider transactions is a common practice in financial analysis.
• Comparing the volume and frequency of insider trading activity at GoodRx to its peers in the healthcare technology sector (e.g., Teladoc, Amwell) can provide insights into relative management confidence.
• The disposal of shares to cover tax obligations is a routine event and doesn't necessarily indicate a negative outlook.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders as they are related to executive compensation and tax obligations.
• Transparency in insider trading activity can contribute to investor confidence.

Key Dates